Base de dados : MEDLINE
Pesquisa : C15.604.744 [Categoria DeCS]
Referências encontradas : 6393 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 640 ir para página                         

  1 / 6393 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29429163
[Au] Autor:Wu YL; Wu F; Yang L; Sun H; Yan XC; Duan GJ
[Ad] Endereço:Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), PLA, Chongqing 400038, China.
[Ti] Título:[Clinicopathologic features and prognosis of inflammatory pseudotumor-like follicular dendritic cell sarcomas in liver and spleen: an analysis of seven cases].
[So] Source:Zhonghua Bing Li Xue Za Zhi;47(2):114-118, 2018 Feb 08.
[Is] ISSN:0529-5807
[Cp] País de publicação:China
[La] Idioma:chi
[Ab] Resumo:To investigate the clinicopathological features and prognostic parameters of the inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS) of liver and spleen. Ninteen cases of inflammatory pseudotumor (IPT) and 5 cases of IPT-like FDCS of the liver and spleen were collected at the First Affiliated Hospital, Army Medical University from 2006 to 2016. HE sections, immunohistochemical staining, and Epstein-Barr virus encoded nuclear RNA (EBER) in situ hybridization were reviewed along with a summary of the literature. Among the previously diagnosed 19 cases of IPT of the liver and spleen, 2 cases were misdiagnosed (the ratio of 2/19). Among 7 new cases including 3 males and 4 females, 3 cases involved the liver and 4 cases involved the spleen. The age range was 37-64 years (mean 53 years). The maximum tumor diameter ranged from 3.0 to 11.0 cm (mean 6.5 cm). Surgical resections were performed in all patients with follow-up time ranging from 3 to 84 months.All patients were disease-free.7 new cases were all positive for EBER, and showed the expression of at least one of the FDC markers, including CD21, CD23, and CD35. The rest of 17 cases of IPT were all negative for EBER and essentially negative for FDC markers, but were all positive for SMA. IPT-like FDCS of the liver and spleen is a rare low-grade malignant tumor morphologically mimicking inflammatory pseudotumor, and is easy to be misdiagnosis due to under-recognition. EBER in situ hybridization and FDC markers are indispensable for confirming the diagnosis.
[Mh] Termos MeSH primário: Granuloma de Células Plasmáticas/patologia
Hepatopatias/patologia
Esplenopatias/patologia
[Mh] Termos MeSH secundário: Adulto
Sarcoma de Células Dendríticas Foliculares/patologia
Feminino
Herpesvirus Humano 4/genética
Seres Humanos
Hibridização In Situ
Masculino
Meia-Idade
Prognóstico
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180306
[Lr] Data última revisão:
180306
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180213
[St] Status:MEDLINE
[do] DOI:10.3760/cma.j.issn.0529-5807.2018.02.007


  2 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29419664
[Au] Autor:Lin H; Wang X; Du X; Wang J; Li Y; Zhang R
[Ad] Endereço:The First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou.
[Ti] Título:Effect of Zhizhu Kuanzhong capsule on functional dyspepsia: Protocol for a systematic review and meta-analysis of randomized controlled trials.
[So] Source:Medicine (Baltimore);97(6):e9731, 2018 Feb.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Functional dyspepsia (FD) is a gastrointestinal disorder affecting people in the globe. Spleen-deficiency syndrome is one of its basic syndromes. Zhizhu Kuanzhong capsule was the most frequent Chinese herbal formula used in the spleen-deficiency researches. We aim to assess the effectiveness and safety of Zhizhu Kuanzhong capsule on FD. METHODS: A systematic literature search for randomized controlled trials (RCTs) from their inception until December 31, 2017 will be conducted using 7 databases: PubMed, Cochrane Library, Embase, VIP Database, Chinese National Knowledge Infrastructure, Wanfang Data, and Chinese BioMedical Database. Inclusion the trials of Zhizhu Kuanzhong capsule which evaluate motilin level, clinical syndrome, and side effect in people with FD. The primary outcome measures will be motilin level, clinical syndrome integral, and clinical total effective rate. Data extraction and risk of bias assessments will be performed by 2 reviewers independently. Methodological and reporting quality of included studies will be assessed by the consolidated standards of reporting trials for Chinese herbal medicine formulas. All statistical analyses will be conducted using RevMan V.5.3 software. Funnel plots, Begg's test, and Egger's test will be developed to evaluate reporting bias. RESULTS: This review will assess the effect of Zhizhu Kuanzhong capsule on clinical total effective rate, symptom remission rate, plasma motilin level, and safety of FD in patients. CONCLUSION: The conclusion of our study will provide updated evidence to judge whether Zhizhu Kuanzhong capsule is an effective intervention for patients with FD.
[Mh] Termos MeSH primário: Medicamentos de Ervas Chinesas/farmacologia
Dispepsia/tratamento farmacológico
Gastroenteropatias/tratamento farmacológico
Metanálise como Assunto
Fitoterapia
Esplenopatias
[Mh] Termos MeSH secundário: Gastroenteropatias/complicações
Gastroenteropatias/diagnóstico
Gastroenteropatias/fisiopatologia
Seres Humanos
Ensaios Clínicos Controlados Aleatórios como Assunto
Projetos de Pesquisa
Esplenopatias/tratamento farmacológico
Esplenopatias/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Drugs, Chinese Herbal)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180216
[Lr] Data última revisão:
180216
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180209
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009731


  3 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390481
[Au] Autor:Araújo NC; Orlando MMC; Neves MB; Rioja SS; de Lucena SBG; Mandarim-de-Lacerda CA
[Ad] Endereço:Division of Nephrology.
[Ti] Título:Howell-Jolly bodies and liver-spleen scanning for assessment of splenic filtrative function yields discordant results in renal transplant recipients.
[So] Source:Medicine (Baltimore);96(51):e9242, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Given discrepancies between methods for diagnosing hyposplenism, the purpose of this study was to evaluate the effect of the spleen size on the correlation between the methods, and to propose a model for improving the interpretation. Patients with renal allografts were included, in whom the spleen was assessed using Doppler ultrasound, scintiscan, and the presence of Howell-Jolly bodies (HJBs) in peripheral smears. In 35 subjects, scintiscan and HJBs were normal (Group 0); 20 had an abnormal result in both methods (Group 1); 34 had discordant results with HJBs present (Group 2); and 14 had discordant results with decreased spleen uptake (Group 3). There was no association between HJBs and scintiscan. The patients of Groups 1 and 2 had smaller spleens. The patients with smaller spleen had more hematological evidence of hyposplenism and exhibit smaller discrepancies between the methods than patients with larger spleen. The spleen can tip the balance from a normal to impaired function provided that the spleen size is below the critical mass required to maintain splenic function. A mild impairment of phagocytic function and slight dyserythropoiesis along with a small spleen would result in decreased take up of radiocolloid or the appearance of HJBs in blood smears.
[Mh] Termos MeSH primário: Inclusões Eritrocíticas/patologia
Transplante de Rim
Fígado/diagnóstico por imagem
Baço/diagnóstico por imagem
Esplenopatias/diagnóstico por imagem
[Mh] Termos MeSH secundário: Adulto
Idoso
Aloenxertos
Análise de Variância
Distribuição de Qui-Quadrado
Estudos Transversais
Feminino
Seguimentos
Seres Humanos
Falência Renal Crônica/cirurgia
Fígado/fisiopatologia
Masculino
Meia-Idade
Estudos Prospectivos
Cintilografia/métodos
Baço/anormalidades
Esplenopatias/fisiopatologia
Ultrassonografia Doppler em Cores/métodos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009242


  4 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29365300
[Au] Autor:Gupta A; Jain P
[Ad] Endereço:Max Super Specialty Hospital, Dehradun, India mail.guptaankur@gmail.com.
[Ti] Título:Calcified Spleen and Gallstones.
[So] Source:N Engl J Med;378(4):380, 2018 Jan 25.
[Is] ISSN:1533-4406
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Calcinose/diagnóstico por imagem
Cálculos Biliares/diagnóstico por imagem
Esplenopatias/diagnóstico por imagem
[Mh] Termos MeSH secundário: Adulto
Calcinose/complicações
Cálculos Biliares/complicações
Hepatite C Crônica/complicações
Seres Humanos
Masculino
Radiografia
Baço/diagnóstico por imagem
Esplenopatias/complicações
Tomografia Computadorizada por Raios X
Talassemia beta/complicações
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180208
[Lr] Data última revisão:
180208
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180125
[St] Status:MEDLINE
[do] DOI:10.1056/NEJMicm1703915


  5 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29200145
[Au] Autor:Gao YJ; Su M; Tang JY; Pan C; Chen J
[Ad] Endereço:Key Laboratory of Pediatric Hematology & Oncology, Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
[Ti] Título:Treatment Outcome of Children With Multisystem Langerhans Cell Histiocytosis: The Experience of a Single Children's Hospital in Shanghai, China.
[So] Source:J Pediatr Hematol Oncol;40(1):e9-e12, 2018 Jan.
[Is] ISSN:1536-3678
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:We reported the outcome of 150 children newly diagnosed with multisystem langerhans cell histiocytosis following a langerhans cell histiocytosis-II-based protocol (arm B). However, the continuation treatment was extended to 56 weeks and etoposide was omitted from the continuation treatment. Risk organ (RO) involvement was defined as: liver (≥3 cm with or without functional impairment); spleen (≥2 cm below the costal margin in the midclavicular line); hematopoietic system (hemoglobin <100 g/L, and/or white blood cell count <4.0×10/L, and/or platelets <100×10/L). The lungs are not considered a RO in the current study. For the 59 patients with RO involvement (RO+), the rapid response rate (week 6) was 61.0% and the 3-year overall survival 73.4%±5.9%. Rapid responders had a better 3-year survival rate than poor responders (90.9%±5.0% vs. 45.7%±11.0%, P<0.001). Ninety-one patients without RO involvement (RO-) had a relatively low 3-year cumulative reactivation rate (10.7%). No deaths occurred in this subgroup and the 3-year overall survival of RO- patients was 100%. Poor responders of RO+ patients had an extremely poor prognosis. An effective salvage therapy is essential for this high-risk group. The initial treatment intensity and duration of continuation therapy both impact disease reactivation in RO- patients.
[Mh] Termos MeSH primário: Histiocitose de Células de Langerhans/diagnóstico
Histiocitose de Células de Langerhans/terapia
Medição de Risco
[Mh] Termos MeSH secundário: Adolescente
Criança
Pré-Escolar
China
Feminino
Sistema Hematopoético/patologia
Histiocitose de Células de Langerhans/mortalidade
Histiocitose de Células de Langerhans/patologia
Hospitais Pediátricos
Seres Humanos
Lactente
Hepatopatias
Masculino
Terapia de Salvação
Esplenopatias
Taxa de Sobrevida
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180112
[Lr] Data última revisão:
180112
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171205
[St] Status:MEDLINE
[do] DOI:10.1097/MPH.0000000000001016


  6 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27771992
[Au] Autor:Mantas D; Damaskos C; Dailiani P; Samarkos M; Korkolopoulou P
[Ad] Endereço:a 2nd Department of Propedeutic Surgery , Athens Medical School, National and Kapodistrian University of Athens , Goudi, Athens , Greece.
[Ti] Título:Castleman's disease of the spleen.
[So] Source:Acta Chir Belg;117(3):203-208, 2017 Jun.
[Is] ISSN:0001-5458
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Castleman's disease (CD), also known as giant or angiofolicular lymphoid hyperplasia or lymphoid hamartoma, is a group of atypical lymphoproliferative disorders that share common lymph node histological features and may be localized either to a single lymph node (unicentric) or occur systemically (multicentric). PATIENT AND METHOD: Herein, we present a rare case of a of 75-year-old female patient who was referred to our department and after a thorough work-up, underwent splenectomy with synchronous resection of an accessory spleen, splenic artery lymph nodes, and splenic hilar lymph nodes due to splenic involvement in a multicentric CD. RESULTS: The pathology of the specimens led to the conclusion that it was a case of polycentric HHV-8-positive CD, affecting the spleen, the accessory spleen, and the lymph nodes. CONCLUSIONS: Incidence of this rare condition is believed to be approximately 0.001-0.05%. CD has been linked to the human immunodeficiency virus (HIV), human herpes virus 8 (HHV-8), and is associated with malignancies. The pathogenesis mechanism is considered to be a dysregulation and hypersecretion of cytokines, either idiopathic or secondary to a viral infection, with the latter considered the most frequent. Solid organ involvement is very rare as is splenic involvement.
[Mh] Termos MeSH primário: Doença de Castleman/diagnóstico
Esplenopatias/diagnóstico
[Mh] Termos MeSH secundário: Idoso
Doença de Castleman/cirurgia
Feminino
Seres Humanos
Esplenectomia
Esplenopatias/cirurgia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180111
[Lr] Data última revisão:
180111
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE
[do] DOI:10.1080/00015458.2016.1246273


  7 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29191451
[Au] Autor:Banerjee S; Sinha K; Chowdhury S; Sil PC
[Ad] Endereço:Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India.
[Ti] Título:Unfolding the mechanism of cisplatin induced pathophysiology in spleen and its amelioration by carnosine.
[So] Source:Chem Biol Interact;279:159-170, 2018 Jan 05.
[Is] ISSN:1872-7786
[Cp] País de publicação:Ireland
[La] Idioma:eng
[Ab] Resumo:cis-Diamminedichloroplatinum (cisplatin) is an effective chemotherapeutic and is widely used for the treatment of various types of solid tumors. Bio-distribution of cisplatin to other organs due to poor targeting towards only cancer cells constitutes the backbone of cisplatin-induced toxicity. The adverse effect of this drug on spleen is not well characterized so far. Therefore, we have set our goal to explore the mechanism of the cisplatin-induced pathophysiology of the spleen and would also like to evaluate whether carnosine, an endogenous neurotransmitter and antioxidant, can ameliorate this pathophysiological response. We found a dose and time-dependent increase of the pro-inflammatory cytokine, TNF-α, in the spleen tissue of the experimental mice exposed to 10 and 20 mg/kg body weight of cisplatin. The increase in inflammatory cytokine can be attributed to the activation of the transcription factor, NF-ĸB. This also aids in the transcription of other pro-inflammatory cytokines and cellular adhesion molecules. Exposure of animals to cisplatin at both the doses resulted in ROS and NO production leading to oxidative stress. The MAP Kinase pathway, especially JNK activation, was also triggered by cisplatin. Eventually, the persistence of inflammatory response and oxidative stress lead to apoptosis through extrinsic pathway. Carnosine has been found to restore the expression of inflammatory molecules and catalase to normal levels through inhibition of pro-inflammatory cytokines, oxidative stress, NF-ĸB and JNK. Carnosine also protected the splenic cells from apoptosis. Our study elucidated the detailed mechanism of cisplatin-induced spleen toxicity and use of carnosine as a protective agent against this cytotoxic response.
[Mh] Termos MeSH primário: Antineoplásicos/toxicidade
Carnosina/farmacologia
Cisplatino/toxicidade
Baço/efeitos dos fármacos
Esplenopatias/induzido quimicamente
[Mh] Termos MeSH secundário: Animais
Carnosina/administração & dosagem
Regulação da Expressão Gênica/efeitos dos fármacos
Masculino
Camundongos
Óxido Nítrico/sangue
Baço/fisiopatologia
Esplenopatias/prevenção & controle
Fator de Necrose Tumoral alfa/genética
Fator de Necrose Tumoral alfa/metabolismo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antineoplastic Agents); 0 (Tumor Necrosis Factor-alpha); 31C4KY9ESH (Nitric Oxide); 8HO6PVN24W (Carnosine); Q20Q21Q62J (Cisplatin)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180103
[Lr] Data última revisão:
180103
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171202
[St] Status:MEDLINE


  8 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Chile
[PMID]:29189866
[Au] Autor:Radich R J; Álvarez Z C; Valenzuela R A; Castillo H F; Moraga V F; Castillo A J
[Ad] Endereço:Departamento de Cirugía, Universidad de Chile, Santiago, Chile.
[Ti] Título:[Role of surgery in Saprochaete capitata (S. capitata) sepsis in a patient with acute myeloid leukemia].
[Ti] Título:Rol de la cirugía en el manejo de la infección invasora por Saprochaete capitata..
[So] Source:Rev Med Chil;145(8):1067-1071, 2017 Aug.
[Is] ISSN:0717-6163
[Cp] País de publicação:Chile
[La] Idioma:spa
[Ab] Resumo:Saprochaete capitata (S. capitata) fungal sepsis is a severe condition with a clinical presentation that is similar to other yeast originated fungal sepsis. It is observed in patients with hematological malignancies such as acute myeloid leukemia and neutropenia. We report a 23 year old male presenting with cough, fever and malaise. A bone marrow biopsy led to the diagnosis of acute myeloid leukemia. During the first cycle of chemotherapy the patient presented fever: blood cultures were positive for Klebsiella pneumoniae. Despite antimicrobial treatment, fever persisted; a computed tomography showed a focal splenic lesion; a left exudative pleural effusion appeared. A Matrix Assisted Laser Desorption Ionization-Time of Flight mass spectrometry identified the presence of S. capitata. After multiple antifungal treatments and pleural cavity cleansing by means of videothoracoscopy and laparoscopic splenectomy, the infection resolved and the patient completed his chemotherapy.
[Mh] Termos MeSH primário: Dipodascus/isolamento & purificação
Fungemia/cirurgia
Leucemia Mieloide Aguda/microbiologia
[Mh] Termos MeSH secundário: Antifúngicos/uso terapêutico
Drenagem/métodos
Fungemia/tratamento farmacológico
Fungemia/patologia
Seres Humanos
Masculino
Pleurisia/microbiologia
Pleurisia/patologia
Esplenectomia/métodos
Esplenopatias/microbiologia
Esplenopatias/patologia
Esplenopatias/cirurgia
Resultado do Tratamento
Adulto Jovem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antifungal Agents)
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171218
[Lr] Data última revisão:
171218
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171201
[St] Status:MEDLINE


  9 / 6393 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28471628
[Au] Autor:Shadafny N; Heyman SN; Bursztyn M; Dinaburg A; Nir-Paz R; Ackerman Z
[Ad] Endereço:Department of Medicine, Hadassah-Hebrew University Hospitals, Jerusalem, Israel.
[Ti] Título:Multiple Sterile Splenic and Lymph Node Abscesses in a Patient with Long-Standing Ulcerative Colitis.
[So] Source:Isr Med Assoc J;18(10):633-635, 2016 Oct.
[Is] ISSN:1565-1088
[Cp] País de publicação:Israel
[La] Idioma:eng
[Mh] Termos MeSH primário: Abscesso/etiologia
Colite Ulcerativa/complicações
Linfonodos/patologia
Esplenopatias/etiologia
[Mh] Termos MeSH secundário: Abscesso/diagnóstico por imagem
Adulto
Colite Ulcerativa/fisiopatologia
Seres Humanos
Linfonodos/diagnóstico por imagem
Masculino
Tomografia Computadorizada com Tomografia por Emissão de Pósitrons/métodos
Índice de Gravidade de Doença
Esplenopatias/diagnóstico por imagem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171128
[Lr] Data última revisão:
171128
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170505
[St] Status:MEDLINE


  10 / 6393 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29078866
[Au] Autor:López JJ; Lodwick DL; Cooper JN; Hogan M; King D; Minneci PC
[Ad] Endereço:Center for Surgical Outcomes Research, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio.
[Ti] Título:Sclerotherapy for splenic cysts in children.
[So] Source:J Surg Res;219:1-4, 2017 Nov.
[Is] ISSN:1095-8673
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Sclerotherapy has been described as a treatment option for nonparasitic pediatric splenic cysts; however, there are limited data on its long-term effectiveness. METHODS: We performed a retrospective review and prospective follow-up imaging study of children treated for nonparasitic splenic cysts at our institution during 2006-2015. Included patients had International Classification of Disease, Ninth Revision, Clinical Modification diagnosis code 289.59 or 759.0 and underwent either sclerotherapy or a partial splenic operation (partial splenectomy, cyst excision, or marsupialization). Charts were reviewed for demographics, imaging, treatments, and complications. Identified patients were contacted and asked to return for splenic ultrasonography. RESULTS: Six surgical patients and 19 sclerotherapy patients were identified. Sclerotherapy patients underwent a median of four treatments with a decrease in the size of the cyst or complete ablation in 89.5% (17/19). Of the two patients who underwent unsuccessful sclerotherapy, one patient had sclerotherapy with sotradecol and ethanol for eight treatments, developed infection, and underwent total splenectomy. The other patient did not improve with sclerotherapy and underwent partial splenectomy. Nine patients (eight patients treated with sclerotherapy and one patient treated with partial splenectomy) were successfully contacted and underwent follow-up imaging at a median follow-up of 2.4 y since last treatment. Of the eight patients treated with sclerotherapy, four patients remained cyst-free, three had small residual asymptomatic cysts stable in size, and one developed a recurrent small asymptomatic cyst; the patient treated with surgery had no recurrence. CONCLUSIONS: Sclerotherapy appears to be an effective and durable alternative treatment for children with splenic cysts.
[Mh] Termos MeSH primário: Cistos/terapia
Escleroterapia
Esplenopatias/terapia
[Mh] Termos MeSH secundário: Adolescente
Criança
Cistos/diagnóstico por imagem
Feminino
Seguimentos
Seres Humanos
Masculino
Estudos Prospectivos
Recidiva
Estudos Retrospectivos
Esplenectomia
Esplenopatias/diagnóstico por imagem
Resultado do Tratamento
Ultrassonografia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171109
[Lr] Data última revisão:
171109
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171029
[St] Status:MEDLINE



página 1 de 640 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde